contamination of urine by seminal fluid. To this end, 480 seminal fluids from nonathletes were analyzed to identify concentration ranges and metabolite profiles of therapeutic drugs that are also classified

fraction) and human liver microsomes (HLMs) were analyzed. In addition, selected metabolites of SLU-PP-915 were synthesized and their structures were analyzed by nuclear magnetic resonance (NMR) spectroscopy

administration studies with 1, 10, and 50 μg of S-23 were conducted, and collected urine samples were analyzed by LC–MS/MS following enzymatic hydrolysis and solid-phase extraction. The analytical method was

gamma irradiation and 15 days of subsequent ex vivo storage on the cytosolic red blood cell proteome analyzed by 2D-DIGE and Orbitrap MS. Proteomics Clin Appl. 2013 May 13. doi: 10.1002/prca.201300009. [Epub [...] H., Schänzer, W., Thevis, M., Storage-induced changes of the cytosolic red blood cell proteome analyzed by 2D DIGE and high-resolution/high-accuracy MS. Proteomics 2012, 12(21), 3263 3272 Walpurgis K [...] Thevis M. Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the cologne doping control laboratory 2009. Drug Test Anal. 2010 Nov;2(11-12):533-7 Kohler M

Sixty participants, in four groups, younger than 12, 15, 16. and 23 yr (U12, U15, U16, U23), were analyzed. A Footbonaut, equipped with a 3D motion capture system consisting of 16 cameras, was used to capture

samples were prepared for analysis using enzymatic hydrolysis followed by solid-phase extraction and analyzed via LC-HRMS/MS. Including isomers, a total of 15 phase I metabolites were detected in the urine

exploratory study, urine samples collected post-administration of 1.5 and 2.0 g of hypoxen were analyzed by means of liquid chromatography-high resolution/high mass accuracy (tandem) mass spectrometry

by gas chromatography/tandem mass spectrometry. All 23 commercially available hemp products were analyzed, and assay characteristicssuch as selectivity, limit of detection, limit of identification, limit

via Internet-based providers and advertised as EPO -gene- and IGF1 -gene-containing materials were analyzed for the presence of potential gene doping agents using a newly developed analytical approach, allowing

volunteers ingested 20 mg of either flmodafinil or fladrafinil. Urine and blood (DBS) samples were analyzed by means of LC-HRMS, where limits of detection between 0.2 and 4 ng/mL were accomplished. After